Showing 1 - 8 results of 8 for search 'Xiaorong Dong', query time: 0.02s
Refine Results
-
1
Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut–Brain Axis Therapies by Mengting Li, Fan Tong, Bian Wu, Xiaorong Dong
Published 2024-12-01Get full text
Article -
2
Roles of the phagocytosis checkpoint in radiotherapy by Yulan Kui, Fan Tong, Ruiguang Zhang, Jian Wang, Xiaorong Dong
Published 2025-08-01Get full text
Article -
3
Preparation and Properties of Antifreeze Rewarming Hydrogel Dressings by Meng Yan, Xiaorong Dong, Jingjing Sun, Yijun Liu, Shengchao Yang, Xing Tian, Shuang Zheng, Lisha Yin, Yanan Fu, Dongmei Li, Lin Cui, Gang Li, Zhongpeng Qiu, Zhiyong Liu
Published 2025-02-01Get full text
Article -
4
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small c... by Mengqing Xie, Minwei Bao, Xiaorong Dong, Lin Wu, Li Liu, Jing Zhao, Xiangling Chu, Yan Wu, Xianxiu Ji, Yujia Fang, Xin Yu, Shiji Zhang, Qi Wang, Tao Hu, Jin Wang, Changbin Zhu, Chunxia Su
Published 2025-05-01Get full text
Article -
5
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC by Lianxi Song, Liang Zeng, Qinqin Xu, Yizhi Li, Wenhuan Guo, Shaoding Lin, Wenjuan Jiang, Zhan Wang, Li Deng, Zhe Huang, Haoyue Qin, Huan Yan, Xing Zhang, Fan Tong, Ruiguang Zhang, Zhaoyi Liu, Lin Zhang, Juan Yu, Xue Yang, Yang Xia, Xiaorong Dong, Gao Zhang, Nong Yang, Yongchang Zhang
Published 2025-09-01Get full text
Article -
6
Efficacy and safety of IBI351 (fulzerasib) monotherapy in KRASG12C inhibitor-naïve Chinese patients with KRAS G12C-mutated metastatic colorectal cancer: a pooled analysis from phas... by Ying Yuan, Yanhong Deng, Yongdong Jin, Zengqing Guo, Yueyin Pan, Cunji Wang, Zhiwu Wang, Yi Hu, Dong Hua, Xiangjiao Meng, Zhiye Zhang, Mingfang Zhao, Xiaorong Dong, Dingzhi Huang, Xiaoyan Li, Lian Liu, Meili Sun, Huijuan Wang, Xiuwen Wang, Nong Yang, Mingjun Zhang, Sheng Hu, Dongde Wu, Jingjing Huang, Sujie Zhang, Mengna Huang, Kefeng Ding
Published 2025-07-01Get full text
Article -
7
Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study by Jian Zhang, Ping Lu, Hui Zhao, Jianhua Chen, Wei Shi, Xiubao Ren, Yi Hu, Liping Wang, Hongmei Zhang, Chengchu Zhu, Jianping Xiong, Jianying Zhou, Jun Zhao, Yongqian Shu, Caicun Zhou, Xiaorong Dong, Yunpeng Liu, Yunchao Huang, Jian Zhao, Yiping Zhang, Sheng Hu, Xiaoyan Lin, Yueyin Pan, Jiuwei Cui, Lizhu Lin, Kangsheng Gu, Yun Fan, Qun Chen, Gongyan Chen, Zhehai Wang, Fengying Wu, Guangyu An, Shuliang Guo, Xiaodong Jiang, Yongsheng Wang, Jifeng Feng, Jianhua Shi, QiMing Wang, Jianan Huang, Lejie Cao, Jianhua Chang, Zhiyong He, Jian Fang, Faguang Jin, Hongjun Gao, Cuimin Ding, Xiangdong Zhou, Anwen Liu, Jianjin Huang, Beili Gao, Yinglan Chen, Chengping Hu, Zhigao Wang, Xinjing Ma
Published 2024-11-01Get full text
Article -
8
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III tri... by Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qiming wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Jie Weng, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Hongying Wei, Jiawei Wei, Zheyu Zhang, Qiong Wu
Published 2024-09-01Get full text
Article